UBS Recommends Buying The Dip On Diplomat Pharmacy
October 21, 2015 at 14:33 PM EDT
UBS initiated coverage of Diplomat Pharmacy Inc (NYSE: DPLO) with a Buy rating and $35 price target on Wednesday. The stock ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.